Search

everythinglearnresearchcommunity

for

Search:↓

Body-hair transplant successfully improved scarred areas and frontal hair density without visible chest scarring.

Fat micrografting improves hair transplant success in burn-related hair loss.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Type 2 diabetes, bacterial scalp infections, and tight hairstyles like braids and weaves are linked to a higher risk of a scarring hair loss condition in African American women.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Immune privilege collapse in hair follicles may cause permanent hair loss in certain conditions.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Cicatricial alopecia may be caused by immune attacks on hair follicles, gland issues, or stem cell damage.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Accurate diagnosis and tailored treatment are crucial for managing complex hair loss conditions.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Chinese patients with primary cicatricial alopecia often have folliculitis decalvans, benefit from treatment, but may experience relapse, with dermoscopy being a useful diagnostic tool.

Hair loss in black women needs more research, early intervention, and community education.

Traction may not be the only cause of cicatricial marginal alopecia.

Erlotinib can cause hair loss as a side effect.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Similar treatments might work for different types of scarring hair loss.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.